Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
The new revisions of the Annexes of the European Union’s chemical legislation with regards to nanomaterials will provide more structure and clarity, but they will also force manufacturers, importers and downstream users to put substantial effort into understanding the details of what should and should not be done.
The proposal for a reporting checklist for papers published in the area of nanobiomedicine is an opportunity to rekindle a conversation that started six years ago.
Initial studies indicate that consumer concerns about nanomaterial use in point-of-use water systems may be overestimated by manufacturers. Nevertheless, manufacturers should continue to focus on building consumer confidence in the safety of their products.